Glomerular amyloid deposits typically involve the mesangium and are described as acellular, amorphous and negative with Jones methenamine silver stain [1]. A 71-year-old While male patient with a history of kappa light chain-only smoldering multiple myeloma underwent percutaneous kidney biopsy for nephrotic range proteinuria. Light microscopy showed diffuse and global amorphous mesangial deposits, which appeared intensely silver-positive, staining in black (Fig. 1A); segmental spicules departing from capillary loops were also visible (Fig. 1, panel A, arrow). Deposits stained positive with Congo red and showed typical apple-green birefringence under polarized light (Fig. 2A). Immunofluorescence identified kappa light chain restriction (Fig. 3). Electron microscopy confirmed the presence of mesangial randomly arranged fibrils with a diameter of 7–12 nm, positive for kappa light chain with immunogold labeling (Fig. 2B). A diagnosis of kidney limited monoclonal light chain (AL) amyloidosis was made. Silver-negativity of amorphous mesangial deposits is one of the classical morphological features of kidney AL amyloidosis [1]. Silver-positive kidney amyloid deposits have been previously described only in heavy chain or light-and-heavy chain amyloidosis, and are a relatively rare occurrence (6% of cases) [2].
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.